Bronchodilators are the first-line therapy for all patients. With COPD disease progression, combination therapy is often required to control the symptoms, which include 2 bronchodilators, such as a long-acting beta-2 agonist (LABA), plus a long-acting muscarinic antagonist (LAMA). This therapy ...
Medication Update. New medication approved for COPD.The article reports that the Aclidinium bromide, a long acting antimuscarinic agent was approved for the maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), chronic bronchitis and emphysema....
“We hope in this way to develop long term treatments that induce lung tissue repair in the patients.” In the future, the research team believes their findings can contribute to drug development and mechanistic studies in patient derived lung tissue. Eventually, they hope their discovery will ...
Adherence to the GOLD Guideline in COPD Management of South Korea: Findings from KOCOSS Study 2011–2018 Therefore, to examine the adherence to the GOLD guidelines, we examined the patterns of prescribed medication in COPD patients from 2011 to 2018. Patients... TO Kim,HJ Shin,YI Kim,......
However, for patients with lung cancer who are not candidates for surgical resection—this includes individuals with underlying conditions that preclude them from meeting surgical criteria or those with tumors in highly compromised locations—conventional radio-chemotherapy is typically the treatment of ...
Previous studies on the benefits of NMS have been focused on costs, including evaluation of cost-effectiveness of the service and pharmacist work. In England, for example, pharmacists provided telephone counselling to 500 patients who received a new medication for a chronic disease (eg, asthma, di...
improvements in lung function, breathlessness, quality of life and rescue medication use over Spiriva® right from the initial stages when patients need maintenance therapy.1 These additional benefits could enable patients to remain active and avoid the downward spiral of COPD for as long as ...
COPD," Srivastava said. "Also, aldose reductase inhibitors can be given orally, unlike current inhaler-based treatments, so medication compliance could be better. And finally they can provide an alternative to steroid treatment for patients who either can't take steroids or find that steroids have...
oral antiplatelet and hypoglycemic agents. Now, factor in that diabetes is on the rise in the United States and insulin use is highly predominant, and one can see the argument for the creation and adoption of devices that not only improve therapeutic outcomes but reduce medication misadventures. ...
A new medication called centhaquine has shown efficacy in treating patients with severe blood or fluid loss, according to a study to be presented at the American Heart Association’s Resuscitation Science Symposium 2020. Every year, approximately 600,000 people in the United States and 1.9 milli...